Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
60
NCT05541549
A Phase 2 Study Evaluating JCPyV-specific T Cell Therapy for PML
Phase: Phase 2
Role: Lead Sponsor
Start: Feb 28, 2023
Completion: Apr 30, 2025